152 related articles for article (PubMed ID: 29622471)
1. HbA1C, finding the right target in 2018.
Vela D
Diabetes Metab Syndr; 2018 Jul; 12(4):607-608. PubMed ID: 29622471
[No Abstract] [Full Text] [Related]
2. Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?
Giugliano D; Maiorino MI; Bellastella G; Petrizzo M; Ceriello A; Genovese S; Esposito K
Endocrine; 2015 Sep; 50(1):56-60. PubMed ID: 25672778
[TBL] [Abstract][Full Text] [Related]
3. Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study.
Cokolic M; Lalic NM; Micic D; Mirosevic G; Klobucar Majanovic S; Lefterov IN; Graur M
Wien Klin Wochenschr; 2017 Mar; 129(5-6):192-200. PubMed ID: 27933508
[TBL] [Abstract][Full Text] [Related]
4. Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post-marketing surveillance study in Japan.
Fazeli Farsani S; Taniguchi A; Ikeda R; Brodovicz KG; Bartels DB
J Diabetes Investig; 2019 Sep; 10(5):1246-1253. PubMed ID: 30667173
[TBL] [Abstract][Full Text] [Related]
5. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study.
Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L;
Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157
[TBL] [Abstract][Full Text] [Related]
6. Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.
Jacob L; von Vultee C; Kostev K
J Diabetes Sci Technol; 2017 Jan; 11(1):123-127. PubMed ID: 27402240
[TBL] [Abstract][Full Text] [Related]
7. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
[TBL] [Abstract][Full Text] [Related]
8. Physicians' prescribing patterns for patients with diabetes are changing for the better.
Rodbard HW; Jellinger PS
Am J Med; 2012 Nov; 125(11):e11-2. PubMed ID: 23098867
[No Abstract] [Full Text] [Related]
9. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors.
Mann DM; Woodward M; Ye F; Krousel-Wood M; Muntner P
Arch Intern Med; 2009 Oct; 169(18):1718-20. PubMed ID: 19822830
[No Abstract] [Full Text] [Related]
10. [Polypharmacological treatment of type 2 diabetes in daily clinical practice. A registry-based study in the county of Aarhus].
Kristensen JK; Lauritzen T
Ugeskr Laeger; 2002 Nov; 164(45):5250-3. PubMed ID: 12451923
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic inertia and intensified treatment in diabetes mellitus prescription patterns: A nationwide population-based study in Taiwan.
Huang LY; Yeh HL; Yang MC; Shau WY; Su S; Lai MS
J Int Med Res; 2016 Dec; 44(6):1263-1271. PubMed ID: 28322095
[TBL] [Abstract][Full Text] [Related]
12. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010.
Wong HK; Ong KL; Cheung CL; Cheung BM
Ann Epidemiol; 2014 Jul; 24(7):516-21.e1. PubMed ID: 24935464
[TBL] [Abstract][Full Text] [Related]
13. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.
Burgmann K; Fatio S; Jordi B; Rutishauser J
Swiss Med Wkly; 2013; 143():w13871. PubMed ID: 24163110
[TBL] [Abstract][Full Text] [Related]
14. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
15. Overtreatment of older patients with type 2 diabetes mellitus in primary care.
Hart HE; Rutten GE; Bontje KN; Vos RC
Diabetes Obes Metab; 2018 Apr; 20(4):1066-1069. PubMed ID: 29193555
[TBL] [Abstract][Full Text] [Related]
16. Variation in HbA1c prescription for patients with diabetes in French general practice: an observational study prior to the implementation of a P4P programme.
Chauvel N; Le Vaillant M; Pelletier-Fleury N
Eur J Public Health; 2013 Feb; 23(1):61-6. PubMed ID: 22219502
[TBL] [Abstract][Full Text] [Related]
17. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
[TBL] [Abstract][Full Text] [Related]
18. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
Wens J; Gerard R; Vandenberghe H
Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
[TBL] [Abstract][Full Text] [Related]
19. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
[TBL] [Abstract][Full Text] [Related]
20. Research is needed to determine optimal screening methods to lessen the burden of type 2 diabetes in youth.
Hannon TS
J Adolesc Health; 2014 Feb; 54(2):117-8. PubMed ID: 24445178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
